Connect with us

District of Columbia

Capital Stonewall Democrats clarifies ‘no endorsement’ of Pinto

Says it postponed action on Ward 2 D.C. race until November

Published

on

D.C. Council member Brooke Pinto. (Washington Blade file photo by Michael Key)

The president of the Capital Stonewall Democrats, D.C.’s largest local LGBTQ political group, expressed regret that he did not clarify in an announcement earlier this week that the organization chose to postpone deciding whether to endorse D.C. Council member Brooke Pinto (D-Ward 2) in the city’s June 4 primary election because she is running unopposed in the primary.

“I misspoke, and I take responsibility for that,” Michael Haresign, the group’s president, told the Washington Blade on Thursday. Haresign said that he regrets that he did not inform the Blade in a May 21 interview at a post endorsement party the group held that Pinto’s name was not on the endorsement ballot the group sent to its members earlier this month to vote on the endorsements.

Based on a press release issued by the group on May 21, the Blade reported that Capital Stonewall Democrats announced it had endorsed just four candidates appearing on D.C.’s June 4 primary ballot – President Joe Biden, D.C. Council members Robert White (D-At-Large) and Janeese Lewis Geroge (D-Ward 4), and D.C.’s U.S. Shadow Representative Oye Owolewa (D).

Among the candidates not endorsed that surprised some in the LGBTQ community were Pinto and D.C. Congressional Delegate Eleanor Holmes Norton (D),  who, like Pinto, is a strong LGBTQ community supporter. In the group’s May 21 press release it did not disclose that Pinto’s name was not on the group’s endorsement ballot.

Elizabeth Mitchell, Capital Stonewall’s Vice President for Legislative and Political Affairs, and Austin Naughton, a member of the group’s endorsement committee from Ward 2, contacted the Blade by email on May 23 to point out that the group decided at the committee’s recommendation to postpone a decision on whether to endorse Pinto, and the membership did not vote on a Pinto endorsement.

 “We made a careful and considerate decision as an election committee to not impose upon CM Pinto’s busy schedule at this time as there was no challenger for the primary,” Mitchell told the Blade in an email. “We assured CM Pinto and her campaign that we would revisit the subject of endorsement after the primary as it’s possible a challenger may emerge at that time,” said Mitchell, who added that the group was unaware of anyone emerging to challenge Pinto in the November election.

“As such, we did not include her on our endorsement ballot,” Mitchell said. Mitchell was also referring to the decision not to invite Pinto to one of the group’s candidate forums related to the June 4 primary, even though Pinto made it clear she would be happy to participate in a forum.  

No candidates have emerged in the June 4 primary to challenge Pinto either as Democrats or as members of the city’s two other registered political parties – the Republican and Statehood Green parties. An independent candidate could emerge to challenge Pinto in the November general election, and voters are eligible to vote for a write-in candidate in both the primary and general election.

Mitchell said Norton’s office did not respond to an invitation to participate in the Capital Stonewall Democrats first of two candidate forums and told the group a conflict in her schedule prevented Norton from attending the group’s second candidates forum.

“Her office sent us a very professional letter explaining that she had a prior engagement the evening of our forum and would be unable to attend,” Mitchell said. “We explained that to our members,” according to Mitchell, who added, “She was on our ballot and failed to receive enough votes to win an endorsement.”

 Under the group’s endorsement policy, candidates must receive at least 60 percent of the vote from the members to receive an endorsement. Under that policy, Haresign said the group also did not make an endorsement for the Ward 7 and Ward 8 D.C. Council races or in the race for the D.C. U.S. Shadow Senator seat because no candidate received a 60 percent vote threshold.

Advertisement
FUND LGBTQ JOURNALISM
SIGN UP FOR E-BLAST

District of Columbia

Center Arts Gallery celebration, auction to take place on Oct. 17

D.C. LGBTQ+ Community Center to mark event’s 10th anniversary

Published

on

(Washington Blade file photo by Michael Key)

The D.C. LGBTQ+ Community Center is hosting its 10th anniversary celebration of the opening of its Center Arts Gallery on Saturday, Oct. 17, at the Center’s offices at 1827 Wiltberger St., N.W., from 6 – 9 p.m.

“For 10 years, the D.C. LGBTQ+ Community Center’s Arts Gallery has been more than a place where art is displayed,” a statement released by the center says.

“It has been a space where LGBTQ+ artists are seen, celebrated, and connected to community, and where their work has given expression to the stories of joy, resistance, grief, beauty, survival, courage, and imagination,” the statement adds.

It says those attending the event would have an opportunity to bid on donated artwork in an auction and to meet and interact with “the artists whose creativity has helped bring Center Arts Gallery to life, enjoy wonderful food and music, and celebrate a decade of LGBTQ+ artistic expression.”

But the statement posted on the LGBTQ+ Community Center’s website says free general admission tickets have sold out, with $75 VIP tickets still available. It says the proceeds from ticket sales will be used to help support the LGBTQ+ Community Center’s operations.

Attendees and others were also invited to an event after party at the LGBTQ bar and cafe Spark Social from 9-11 p.m. at 2009 14th St., N.W.

Continue Reading

District of Columbia

Physician: addiction doesn’t always look the way you think it does

Yngvild Olsen headed HHS’s Center for Substance Abuse Treatment during Biden-Harris administration

Published

on

Dr. Yngvild Olsen (Photo courtesy of Olsen)

Many people think the telltale signs of drug addiction include sweating and vomiting. But a prominent addiction medicine physician says the best signals aren’t always so visible. 

Dr. Yngvild Olsen says more accurate signs come from the brain, specifically the compulsion to keep using drugs, including opioids, despite damage to education, career and relationships. 

While it may be harder to understand the true nature of drug addiction, it’s never been more important because of the increased fatality risk of even microscopic amounts of fentanyl, which can be found in many illegal drugs. 

Olsen, who headed the Center for Substance Abuse Treatment at the Department of Health and Human Services in the Biden-Harris administration, has worked in addiction treatment for more than two decades. She is now a healthcare advisor with the law and professional consulting firm Manatt, Phelps & Phillips and a physician at the Institute for Behavior Resources/Reach Health Services in Baltimore. 

Olsen met with Youthcast Media Group to discuss her career, the opioid epidemic and what to know about fentanyl. The physician, a graduate of Harvard Medical School and the John Hopkins Bloomberg School of Public Health, cited her field experiences as key in shaping her perspective on addiction treatment and recovery. This interview is edited for clarity and length. 

What made you believe this work in addiction treatment is important?

I had a couple of experiences really early on in my career that very significantly shaped my interest in addiction and addiction medicine, and my belief that I had a role, and that I could really help people get better from that disease. So the first was during the summer between my first and second year in medical school. I spent the summer on the Eagle Butte and Pine Ridge reservations in South Dakota and really saw firsthand just the devastating impact that substance use — in that case, alcohol — had on not only individuals, but their families and whole communities, and just how profound that impact had been for people who had lost their lives, who had lost family members, who had physically, emotionally and spiritually negative impacts of just feeling very hopeless and and trying to find solace in their substance use, particularly their alcohol use, and doing that without really finding it. I think that was really the lesson that experience taught me. 

What did you learn about treatment practices during your medical education? How was that helpful to your career?

When I was a resident in general primary care at Boston Medical Center, I was really fortunate to have a group of mentors who also were general internists, like I was training to be, who were very interested and focused on medical education and research in substance use. And so they modeled for me many of the interactions that we had with patients. I got to do a research study with one of them looking at smoking cessation among people with opiate use disorder, taking methadone. And really importantly, I got to spend a month with one of them at the Boston City Public Health Department’s Opioid Treatment Program, or what some people call a methadone clinic, because he was their medical director. I got to see people recover, and who had recovered, who had gotten their lives back together, gotten their families back together, had new families (or) businesses. It was unbelievably helpful to see that people could recover, that they did recover, and that I, as a physician, could be part of their treatment. I saw people get better, and recover, with medications like methadone and buprenorphine, and other services designed individually for them. That was really helpful and kind of a big eye-opening moment for me.

What factors contribute to addiction and why is it considered a complex disease?

People come into treatment for their addiction — or when they’re not in treatment, but are in an emergency department or on the street — with a lot of shame. They have a lot of shame about this disease that they have, that for so long, they were told, ‘Well, you know, you should just stop. Why can’t you just stop?’ Well, we know that addiction is a disease. It’s a complex disease that has lots of different factors related to it. So there’s a big genetic component that combines with environmental factors and other risk factors. For example, people have what’s called adverse childhood experiences. Some of these are if they grow up with lots of physical or sexual abuse or emotional abuse or have parents who are in jail. That’s really traumatic and so all those childhood experiences that increase stress are a big risk factor. 

What is the easiest opioid to get addicted to?

It used to be heroin. That was a big problem, particularly in the Northeast and other parts of the country. That shifted to prescription opioids, beginning around the year 2000. So for about 10 years, it was really prescription opioids that were a big problem — people misusing them. And then it switched back to heroin. And then in about 2015, fentanyl came on the scene, and that really changed the game, given just how unbelievably potent fentanyl is, so it doesn’t take a lot to cause an overdose. Now there are all those other synthetic opioids, like the orphines and nitazenes and all those combinations of other substances, but fentanyl is really what’s still kind of driving a really big part of the overdose crisis.

Do LGBTQ individuals face heightened challenges when battling addictions? How do addiction specialists like you account for those challenges?

We certainly know that the prevalence of overdose and the challenges of substances is higher in the LGBTQ+ community. Where I see patients, we did a big LGBTQ+ training and had a grant to specifically provide services to that population. Where we were located, in Baltimore City, there is a big transgender community not that far from us. Particularly in the LGBTQ+ population, they have multiple stigmas. So it just compounds multiple stressors. And stress is a risk factor for substance use, and particularly a risk factor for recurrence of a substance use disorder. And so when you have all these negative factors building up in people, that can make it that much more challenging for people to find the services that they find meaningful and that are welcoming and supportive of them. So we tried very hard — and we still do — to make sure that we are a welcoming and safe space, because I think it is that safety that is really paramount.

What advice would you give someone worried about a friend or family member’s substance use?

There are two things. One is: I would talk to that person about your concerns and how that person’s personality changes or their behavior changes when they’re using or in withdrawal, and how that might be impacting their health and how they’re feeling. And then second: you can let them know that there are actual treatments that are really helpful, that can make them feel better and that can help them get back to who they were before they started using. It’s important not to be accusatory because … [people] have a lot of shame already, and so when somebody starts accusing them, that shame just gets worse. And a lot of times, people who have a substance use disorder or are using opioids won’t necessarily agree that they have a problem when you first start to talk to them. But talk to them again every time something happens and say, ‘I’m really worried about you because this now has happened and I see it as being tied to your substance use.’ And let them know that there are people who can help and that they could actually feel a lot better.

This work is part of a partnership between the Washington Blade Foundation and Youthcast Media Group, funded in part through a FY26 Community Development Grant from the Office of D.C. Mayor Muriel Bowser. Adrian Malone is a senior at Bard High School Early College DC, one of Youthcast Media Group’s journalism class partners. Shreya Jyotishi, YMG assistant manager of content and programming, is a former Washington Blade intern and 2026 graduate of American University.

Continue Reading

District of Columbia

Bet Mishpachah participates in D.C. Oct. 7 commemoration ceremony

Wednesday marked three years since Hamas attacked Israel

Published

on

Bet Mishpachah Executive Director Joshua Maxey speaks at an Oct. 7 commemoration ceremony at Washington Hebrew Congregation in D.C. on Oct. 7, 2026. (Photo courtesy of Joshua Maxey)

Bet Mishpachah Executive Director Joshua Maxey on Wednesday was among those who spoke at a ceremony in D.C. that marked the third anniversary of the Oct. 7 attack in Israel.

The Jewish Federation of Greater Washington hosted the ceremony that took place at the Washington Hebrew Congregation in Northwest D.C. Bet Mishpachah is the city’s LGBTQ synagogue.

“It was a deeply moving evening, especially hearing the stories of people who knew those who were murdered and those who survived and experiencing music that gave a voice to grief and hope,” Maxey told the Washington Blade.

Hamas militants on Oct. 7, 2023, killed roughly 1,200 people, including upwards of 360 partygoers at the Nova Music Festival near Re’im, a kibbutz that is a couple miles from the Gaza Strip, when it launched its surprise attack on Israel. The militants also kidnapped more than 200 people.

The Hamas-controlled Gaza Health Ministry says Israeli forces have killed more than 74,000 people in the enclave since Oct. 7.

The International Criminal Court in 2024 issued arrest warrants for Israeli Prime Minister Benjamin Netanyahu; former Israeli Defense Minister Yoav Gallant; former Hamas leader Yahya Sinwar; Mohamed Diab Ibrahim al-Masri, the head of Hamas’s military wing known as the Qassam Brigades; and Ismail Haniyeh, chair of the Hamas Political Bureau, after it accused them of committing war crimes and crimes against humanity in Gaza and Israel.

The Israeli government has strongly denied it has committed genocide in Gaza.

An Israeli airstrike on a compound in Khan Younis, a city in southern Gaza, on July 13, 2024, killed killed Deif, one of the alleged Oct. 7 masterminds. Israel less than three weeks later assassinated Haniyah in Tehran, the Iranian capital. Israel Defense Forces soldiers on Oct. 16, 2024, killed Sinwar in Rafah, a city in southern Gaza.

Hamas last October released the remaining hostages in Gaza as part of a ceasefire agreement that President Donald Trump helped broker. Israel has continued to conduct airstrikes and other military operations in Gaza since the official suspension of hostilities took effect.

“For Bet Mishpachah, it was especially meaningful to lift up the names of LGBTQ+ people, those whose identities we know and those whose stories may never be fully known, who were murdered, and to honor the LGBTQ+ survivors whose resilience continues to inspire us,” said Maxey, referring to his participation in Wednesday’s ceremony. “Emily Damari’s story is particularly poignant: while held hostage, she had to hide the fact that she was gay because she feared that revealing her identity to her captors could put her life at even more risk. Yet, she survived.”

“Her story, like so many others, reminds us of the extraordinary courage it takes simply to remain human in the face of hatred,” he added. “May we continue to remember and to mourn, to honor, and to work toward a future rooted in peace and hope.”

Continue Reading

Popular